<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230615058489N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-06-25</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>the effect of  low free sugar  diet in patients with polycystic ovary syndrome</public_title>
      <acronym>-</acronym>
      <scientific_title>The effect of low free sugar diet on anthropometric parameters, lipid profile and glycemic control in women with polycystic ovarian syndrome</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-07-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>74</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70811</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In order to randomly assign patients to two groups, stratified blocked randomization method is used based on BMI (overweight or obese). The size of the blocks is 4 blocks, two allocations to the intervention group (A) and two allocations to the control group (B) are considered. 6 permutations including AABB, ABAB, BBAA, BABA, ABBA, BAAB will be created. Finally, these permutations will be used for both BMI blocks.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Polycystic Ovary syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: For 12 weeks, the low free sugar diet (less than 3% of calories are from free sugar) is provided along with the recommendations of a healthy diet and physical activity, and in order to follow the program, a food record is recorded every 2 weeks through A phone call is made. Intervention 2: Control group:  food and physical activity recommendations / 12 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Asal Ataie Jafari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Research and Science Branch, Daneshgah Blvd, Simun Bulivar Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1477893855</zip>
        <telephone>+98 21 4486 5179</telephone>
        <email>asal_ataie2003@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hajar Gholamshahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 212, Dastwara Residential Complex, No. 185, Dastwara Blvd., after Godarzi Alley, South Aliabad, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1838871936</zip>
        <telephone>+98 21 5531 2098</telephone>
        <email>hajar.gholamshahi@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>willingness to participate in research
Age 18-45 years
BMI&gt; 25
Having polycystic ovarian syndrom based on the diagnosis of gynecologist ( According to Rotterdom criteria)
Less than 6 months have passed since diagnosis
People who get more than 10% of their calories from free sugars
Absence of other diseases and chronic and acute disorders of women such as uterine and ovarian cancers
Not suffering from liver diseases, suffering from kidney failure and heart failure, suffering from infectious or inflammatory diseases, suffering from thyroid gland disorders, diabetes, types of cancer, hyperprolactinemia
Not pregnant or breastfeeding
Non-adherence to special diets or weight loss diets in the last three months
Not using hormonal drugs, corticosteroids, omega-3 and spironolactone</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Unwillingness to continue cooperation
Failure to follow the intervention diet for more than 2 days
Starting a new diet other than the nutritional recommendations provided in the control group
pregnancy
Changing the medication regimen, physical activity during the intervention period</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E28.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Polycystic ovarian syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: For 12 weeks, the low free sugar diet (less than 3% of calories are from free sugar) is provided along with the recommendations of a healthy diet and physical activity, and in order to follow the program, a food record is recorded every 2 weeks through A phone call is made.</i_keyword>
      <i_keyword>Control group:  food and physical activity recommendations / 12 weeks</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fasting Blood Glucose (FBG). Timepoint: Beggining and after 12 weeks. Method of measurement: Enzymatic method.</prim_outcome>
      <prim_outcome>Serum insulin. Timepoint: Beggining and after 12 weeks. Method of measurement: ELISA.</prim_outcome>
      <prim_outcome>HOMA-IR. Timepoint: Beggining and after 12 weeks. Method of measurement: Calculate.</prim_outcome>
      <prim_outcome>QUICKI. Timepoint: Beggining and after 12 weeks. Method of measurement: calculate.</prim_outcome>
      <prim_outcome>Serum triglycerides. Timepoint: Beggining and after 12 weeks. Method of measurement: Enzymatic Method.</prim_outcome>
      <prim_outcome>Total serum cholesterol. Timepoint: Beggining and after 12 weeks. Method of measurement: Enzymatic Method.</prim_outcome>
      <prim_outcome>Serum LDL-C. Timepoint: Beggining and after 12 weeks. Method of measurement: Enzymatic Method.</prim_outcome>
      <prim_outcome>Serum HDL-C. Timepoint: Beginning and after 12 weeks. Method of measurement: Enzymatic Method.</prim_outcome>
      <prim_outcome>Weight. Timepoint: Beginning and after 12 weeks. Method of measurement: Scales.</prim_outcome>
      <prim_outcome>Body Mass Index. Timepoint: Beginning and after 12 weeks. Method of measurement: Calculate.</prim_outcome>
      <prim_outcome>Waist to hip ratio. Timepoint: Beginning and after 12 weeks. Method of measurement: Calculate.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-06-10</approval_date>
        <contact_name>Research ethic committee Islamic Azad University_ Science and research Branch</contact_name>
        <contact_address>Science and Research Branch, Daneshgah Blvd,Simon Bulivar Blvd, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
